Document is current

Any future updates will be listed below

Improved health-related quality of life of patients with metastatic renal cell carcinoma treated with a 2 weeks on and 1 week off schedule of sunitinib

Crossref DOI link: https://doi.org/10.1007/s12032-015-0528-8

Published Online: 2015-02-20

Published Print: 2015-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark